20/20 Biolabs, Inc.
AIDX
$0.52
$0.000.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.51M | -2.17M | -1.31M | -825.50K | -840.90K |
| Total Depreciation and Amortization | 19.80K | 17.90K | 20.10K | 21.10K | 21.10K |
| Total Amortization of Deferred Charges | 275.20K | 240.40K | 97.90K | 17.20K | -- |
| Total Other Non-Cash Items | 449.70K | 696.40K | 398.00K | 127.80K | 127.80K |
| Change in Net Operating Assets | 156.20K | -68.90K | 280.00K | 273.80K | 157.90K |
| Cash from Operations | -605.50K | -1.29M | -511.70K | -385.70K | -534.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.50K | -5.40K | -- | -- | -- |
| Cash from Investing | -7.50K | -5.40K | -- | -- | -- |
| Total Debt Issued | 0.00 | 250.00K | 411.90K | 506.60K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 4.80K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.00M | 5.00M | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -60.00K | -762.60K | -23.90K | -- | -- |
| Cash from Financing | 940.00K | 4.49M | 392.80K | 506.60K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 327.00K | 3.19M | -118.90K | 120.90K | -534.10K |